Suppr超能文献

多排螺旋 CT 使用中性口服对比剂评估肠扩张和壁可视化。

Evaluation of bowel distension and mural visualisation using neutral oral contrast agents for multidetector-row computed tomography.

机构信息

Department of Biomedical Imaging, University of Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia.

出版信息

Singapore Med J. 2012 Nov;53(11):732-6.

Abstract

INTRODUCTION

We compared the effectiveness of different types of non-commercial neutral oral contrast agents for bowel distension and mural visualisation in computed tomographic (CT) enterography.

METHODS

90 consecutive patients from a group of 108 were randomly assigned to receive water (n = 30), 3.8% milk (n = 30) or 0.1% gastrografin (n = 30) as oral contrast agent. The results were independently reviewed by two radiologists who were blinded to the contrast agents used. The degree of bowel distension was qualitatively scored on a four-point scale. The discrimination of bowel loops, mural visualisation and visualisation of mucosal folds were evaluated on a 'yes' or 'no' basis. Side effects of the various agents were also recorded.

RESULTS

3.8% milk was significantly superior to water for bowel distension (jejunum, ileum and terminal ileum), discrimination of bowel loops (jejunum and ileum), mural visualisation and visualisation of mucosal folds (ileum and terminal ileum). It was also significantly superior to 0.1% gastrografin for bowel distension, discrimination of bowel loops, mural visualisation and visualisation of mucosal folds (jejunum, ileum and terminal ileum). However, 10% of patients who received 3.8% milk reported immediate post-test diarrhoea. No side effects were documented for patients who received water and 0.1% gastrografin.

CONCLUSION

3.8% milk is an effective and superior neutral oral contrast agent for the assessment of the jejunum, ileum and terminal ileum in CT enterography. However, further studies are needed to explore other suitable oral contrast agents for CT enterography in lactose- or cow's milk-intolerant patients.

摘要

简介

我们比较了不同类型的非商业性中性口服对比剂在 CT 肠造影中对肠道扩张和壁面可视化的效果。

方法

将 108 例患者中的 90 例连续患者随机分为水组(n = 30)、3.8%牛奶组(n = 30)或 0.1%胃泛影葡胺组(n = 30)。结果由两名独立的放射科医生进行盲法评估,两位医生均不知道所使用的对比剂。肠道扩张程度采用四级评分法进行定性评分。肠袢的区分、壁面可视化和黏膜褶皱的可视化均以“是”或“否”为基础进行评估。还记录了各种造影剂的副作用。

结果

3.8%牛奶在肠道扩张(空肠、回肠和末端回肠)、肠袢区分(空肠和回肠)、壁面可视化和黏膜褶皱可视化(回肠和末端回肠)方面均显著优于水。3.8%牛奶在肠道扩张、肠袢区分、壁面可视化和黏膜褶皱可视化(空肠、回肠和末端回肠)方面也显著优于 0.1%胃泛影葡胺。然而,10%接受 3.8%牛奶的患者报告了试验后立即出现腹泻。接受水和 0.1%胃泛影葡胺的患者均无副作用记录。

结论

3.8%牛奶是一种有效的、优于水的中性口服对比剂,可用于 CT 肠造影评估空肠、回肠和末端回肠。然而,还需要进一步研究来探索其他适合乳糖不耐受或牛奶不耐受患者的 CT 肠造影的口服对比剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验